FDA inspection
Cipla Ltd.: FDA inspection ending May 30, 2025
FDA inspection 1271320 · Voluntary Action Indicated (VAI) · Bangalore
Key facts
| Inspection ID | 1271320 |
|---|---|
| Firm | Cipla Ltd. |
| FEI number | 3005857289 |
| Address | 285, 286 and 287, KIADB, IV Phase, Bommasandra-Jigani Link Road |
| City | Bangalore |
| Country | India |
| Fiscal year | 2025 |
| Inspection end date | May 30, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data